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Diagnosis and management of feline diabetes mellitus (Part I) 
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Prof. Dr., Dipl ECVIM-CA 
Clinic for Small Animal Internal Medicine 
Vetsuisse Faculty, University of Zurich 
Winterthurerstrasse 260 
CH-8057 Zurich 
Diabetes mellitus is a common endocrinopathy in cats. Approximately 80% of cats may suffer a type 2 
like diabetes based on clinical characteristics and islet histology. Type 2 diabetes is a heterogeneous 
disease due to a combination of impaired insulin action (insulin resistance) and -cell failure. For both 
defects to develop environmental as well as genetic factors play a role. The latter have not been 
characterized in the cat so far, the most convincing evidence on the existence of genetic factors has 
derived from studies in Australia and the UK in the Burmese cat, in which the frequency of diabetes 
was shown to be clearly higher than in domestic cats.
1,2
 Besides being a Burmese cat other risk 
factors are: increasing age, male gender, being neutered, physical inactivity, glucocorticoid and 
progestin administration and obesity. Similar to humans the most important risk factor is obesity and it 
has been shown that obese cats are 3.9 times more likely to develop diabetes compared to optimal 
weight cats.
3
 Other specific types of diabetes (formerly called secondary diabetes) account for 
approximately 20% of cases and include pancreatitis, hyperadrenocorticism, hypersomatotropism and 
the application of progestins or glucocorticoids.  
Diabetes typically occurs in middle-aged to old cats, with a strong sex predilection for males. 
Approximately 60% of diabetic cats presented to our hospital are mildly to severely overweight. Most 
diabetic cats have the classical symptoms of diabetes, namely polyuria, polydipsia, polyphagia and 
weight loss. About 10% have overt symptoms of diabetic neuropathy, manifested as hind limb 
weakness, decreased ability to jump and plantigrade posture. Cats are prone to stress hyperglycemia 
which has to be differentiated from hyperglycemia due to diabetes by repeated blood glucose 
measurements or by measurement of fructosamine. Further work-up should clarify the severity of 
diabetes and the presence of concurrent disease (e.g. stomatitis, urinary tract infection). Treatment 
should be initiated immediately and include twice daily insulin application (e.g. Caninsulin®, Lantus®) 
and high-protein-low-carbohydrate diet. Initial dosage (Caninsulin, Lantus) in cats weighing < 4 kg is 1 
U/cat given twice daily, cats weighing > 4 kg usually receive 1.5 – 2.0 U/cat twice daily. In cats which 
have a blood glucose concentration < 20 mmol/l at the time of diagnosis, no more than 1 U/cat twice 
daily independent of the body weight is given.
4,5
 
The cat is a true carnivore which distinguishes it clearly from the omnivorous dog. Using low-
carbohydrate-high-protein diet may result in better clinical control and may contribute to diabetic 
remission. Time of feeding relative to the insulin administration does not seem to play a role, the 
feeding schedule should, however, be consistent from day to day, either two equal size meals around 
the time of insulin administration or “nibbling” throughout day and night. Frequent re-evaluations and 
amendments of insulin dosage are essential to achieve a good glycemic control and to increase the 
chance of diabetic remission. In our hospital re-evaluations are performed 1, 3, 8,12 weeks after 
diagnosis and then approximately every 4 months. Ideally, fasting blood glucose (before the insulin 
injection) should be between 12-15 mmol/l and the nadir 5-9 mmol/l. Dosage changes are performed 
with increments of 0.5 U/cat BID approximately every 5 – 7 days.  
The owner should assess his animal with regard to the clinical signs of diabetes mellitus on a daily 
basis. Body weight should be taken at least once a week. It is important that the owner is familiar with 
the clinical signs of the most important complications of diabetes mellitus, i.e. hypoglycemia and 
diabetic ketoacidosis. In general, single measurements are considered insufficient to assess metabolic 
control. Blood glucose curves (BGCs) are necessary to evaluate insulin efficacy, glucose nadir, 
duration of insulin effect, degree of fluctuation and the Somogyi effect. We prefer that owners give 
insulin and food at home, and then bring the animal to the hospital (within 2 hours) for a BGC. 
However, since cats are prone to stress hyperglycemia blood glucose concentrations measured in the 
hospital may not reflect the true glycemic situation. We therefore recommend to the owners of diabetic 
cats to perform so-called home-monitoring (HM) of capillary blood glucose and approximately 70% of 
the owners are willing and able to do this. Usually, we introduce HM 3 weeks after the initial 
presentation. Capillary blood is obtained from the pinna or paw and glucose is determined with a 
portable glucometer (currently with the AlphaTRAK, Abbott Animal Health).
6
 Depending on the 
particular cats we recommend to generate a BGC once a week to once a month. Owners can certainly 
be taught to interpret a BGC; however, we prefer that decisions regarding changes in the insulin dose 
be made by the veterinarian and therefore, BGCs be sent to the hospital. The interpretation of BGCs 
generated at home is similar to those generated in the hospital. The glucose concentration should 
ideally range from 12 – 15 mmol/l before the insulin injection with a nadir from 5 – 9 mmol/l. A low 
nadir may occur in insulin overdose, overlap of insulin actions and lack of food intake. If the nadir is > 
9 mmol/l, insulin underdose, the counter-regulatory phase of the Somogyi effect and technical 
problems involving the injection of insulin by the owner must be considered. The duration of effect is 
defined as the time from insulin injection through the glucose nadir until the blood glucose 
concentration exceeds 12 – 15 mmol/l. If the duration is less than 8 – 10 hours, the animal usually has 
signs of diabetes, and if the duration is longer than 14 hours and the insulin is given twice daily, the 
risk of hypoglycemia increases. One of the major advantages of HM is that it enables frequent 
generation of BGCs, which may be of particular importance in animals that are difficult to regulate. HM 
has replaced measurement of urine glucose nearly completely in our hospital.  
We routinely measure the fructosamine concentration during the re-evaluations. It increases when 
glycemic control worsens and decreases when glycemic control improves. Metabolic control is usually 
good when fructosamine levels are between 350 and 450 μmol/l, moderate when values are between 
450 and 550 μmol/l and poor when levels are > 550 – 600 μmol/l.  
In most cats 2 – 3 months are needed until adequate glycemic control is achieved. It is also mostly 
during the first 3 months that diabetec remission occurs. With the treatment regimen described above 
the current remission rate in our hospital is approximately 50%. Interestingly older cats have a greater 
chance of remission than younger cats.
7
 Close monitoring is required because if improvement of 
glycemic control or diabetic remission happen unnoticed serious hypoglycemia may result. 
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